The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The Food and Drug Administration has upgraded its classification of a broccoli recall initially reported in late December, ...

On Dec. 12, 2024, Cal Yee Farm, a California-based company, announced a recall on a variety of products, including dark ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...

The FDA has upgraded a recall issued on 12-ounce Marketside Broccoli Florets that were initially sold at select Walmart ...

The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.

According to the FDA, If consumers have an allergy or sensitivity to milk, they should not consume the product and discard it ...

The (FDA) has announced several Class 1 recalls, the highest risk level, for various food products sold across multiple ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...